Vifor Pharma to acquire Sanifit

St. Gallen, Switzerland, and Palma, Spain, 22 November 2021 – Vifor Pharma and Sanifit Therapeutics, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced the companies have entered into a definitive agreement. Vifor Pharma will acquire Sanifit, for the continued development and commercialization of SNF472, a novel, first-in-class inhibitor of vascular calcification for the treatment of CUA and PAD in patients with end-stage kidney disease. There are currently no approved medicines indicated for CUA or for PAD specifically in this population. SNF472 has already been granted orphan drug designation for the treatment of CUA and PAD by the US Food and Drug Administration and for CUA by the European Medicines Agency.

Click here to read the press release

Sequotech Group is acquiring UDITIS SA

Delémont, January 6, 2022 – Sequotech Group is acquiring UDITIS SA, a specialized IT services company. Thereby, the Group is …

Read More →

Axcel partners with Picca Automation

In partnership with the owners and management of Picca Automation, Axcel is setting out to create a leading Nordic industrial …

Read More →

Storskogen acquires Trollskes Maskinservice

Storskogen has acquired all the shares in Trollskes Maskinservice AB via its subsidiary Elektroautomatik i Sverige AB. Trollskes Maskinservice performs …

Read More →

VR Equitypartner has acquired a stake in Heizungsdiscount24 GmbH

Frankfurt am Main / Gießen, 04. Januar 2022 – Die Frankfurter Beteiligungsgesellschaft VR Equitypartner erwirbt gemeinsam mit Co-Investoren einen signifikanten …

Read More →

Vestum AB has entered into an agreement to acquire all shares in MCR-companies

Vestum strengthens its position in container rental and related services through acquisition of specialist company with sales of SEK 124m, …

Read More →

Nordstjernan to invest in medtech company Ascilion

Nordstjernan is investing in Ascilion, a Swedish medtech company founded in 2012 and based in Stockholm, Sweden. Ascilion has developed …

Read More →
close-link
close-link